Nisha Joseph, MD¹, Kathryn T. Maples, PharmD^2*, Kevin Hall^1*, Vikas A Gupta, MD, PhD^3*, Larry H. Boise, PhD³, Leonard T. Heffner, MD^4*, Madhav V Dhodapkar, MD³, Craig C. Hofmeister, MD, MPH⁴, Jonathan L. Kaufman, MD⁵, Sagar Lonial, MD, FACP⁶ and Ajay K. Nooka¹

¹Winship Cancer Institute, Emory University, Atlanta, GA
²Winship Cancer Institute, Emory Healthcare, Atlanta, GA
³Emory University, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Atlanta, GA
⁵Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁶Emory University School of Medicine, Atlanta, GA

Alissa Visram, alisvisram@toh.ca^1*, S. Vincent Rajkumar, MD^2*, Prashant Kapoor, MD², Angela Dispenzieri, MD^2*, Martha Q. Lacy, MD³, Morie A. Gertz, M.D.², Francis K. Buadi, MB, CHB^4*, Suzanne R. Hayman, M.D.², David Dingli, M.D., Ph.D.², Taxiarchis Kourelis, MD², Wilson I Gonsalves, MD², Rahma M Warsame, MD², Eli Muchtar, MD², Nelson Leung, MD², Robert A. Kyle, MD² and Shaji K Kumar, MD⁵

¹Division of Hematology, Mayo Clinic, Rochester
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁴Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁵Mayo Clinic, Rochester, MN

Aðalbjörg Ýr Sigurbergsdóttir, BSc^1*, Sæmundur Rögnvaldsson, MD^1*, Sigrun Thorsteinsdottir, MD, PhD^2,3, Ingigerdur Solveig Sverrisdottir, MD, BSc^1*, Gudrun Asta Sigurdardottir^2*, Brynjar Vidarsson, MD⁴, Pall Torfi Onundarson, MD⁴, Bjarni Agnar Agnarsson, MD^4*, Margret Sigurdardottir, MD^4*, Ingunn Thorsteinsdottir, MD, PhD^4*, Isleifur Olafsson, MD, PhD^4*, Asdis Rosa Thordardottir^2*, Gauti Kjartan Gislason, MSc^2*, Andri Olafsson^2*, Petros Kampanis, PhD^5*, Malin Hultcrantz, MD PhD⁶, Brian G.M. Durie, MD⁷, Stephen Harding, PhD⁸, Ola Landgren, MD⁹, Thorvardur Jon Love, MD, PhD^2* and Sigurdur Y Kristinsson, MD, PhD^2,10

¹Faculty of Medicine, University of Iceland, Reykjavík, Iceland
²Faculty of Medicine, University of Iceland, Reykjavik, Iceland
³Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
⁴Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
⁵Binding Site Group Ltd., Birmingham, United Kingdom
⁶Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
⁸The Binding Site Inc., Birmingham, United Kingdom
⁹Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
¹⁰Landspítali - The University Hospital of Iceland, Reykjavik, Iceland

Nadine Abdallah, MD^1*, David L Murray, MD, PhD^2*, Angela Dispenzieri, MD³, Prashant Kapoor, MD¹, Morie A. Gertz, M.D.¹, Martha Q. Lacy, MD⁴, Suzanne R. Hayman, M.D.¹, Francis K. Buadi, MB, CHB^5*, Wilson I Gonsalves, MD¹, Eli Muchtar, MD¹, Nelson Leung, MD⁴, David Dingli, M.D., Ph.D.¹, Taxiarchis Kourelis, MD¹, Rahma M Warsame, MD¹, Moritz Binder, MD, MPH^1*, Robert A. Kyle, MD¹, S. Vincent Rajkumar, MD^1* and Shaji K Kumar, MD³

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁵Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Arghya Ray, PhD¹, Clifton C. Mo, MD², Ting DU, PhD^1*, Arturo Olguin^3*, Janice Chen, PhD^4*, Christopher L Brooks, PhD⁵, Tariq I. Mughal, MD, FRCP^5,6*, Paul G. Richardson, MD⁷, Dharminder Chauhan, PhD^8* and Kenneth C. Anderson, MD⁹

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA
³Stemline Therapeutics Inc., New York, NY
⁴Stemline Therapeutics, New York, NY
⁵Stemline Therapeutics Inc, New York, NY
⁶Tufts University School of Medicine, Boston, MA
⁷Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics,, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁸The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Hannah P. Cutshall^1,2*, Kevin D. Arnold^1* and Elizabeth E. Brown, PhD, MPH^1,3

¹Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
²School of Medicine, University of Alabama at Birmingham, Birmingham, AL
³O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL

Sheila K Pierson, MSc^1*, Adam Bagg, MD², Daisy Alapat, MD³, Megan S. Lim, MD, PhD⁴, Mary Jo Lechowicz, MD⁵, Gordan Srkalovic, MD, PhD⁶, Thomas S. Uldrick, MD, MS⁷, Frits van Rhee, MD PhD⁸ and David C Fajgenbaum, MD, MBA, MSc⁹

¹Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
²Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
³Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁵Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
⁶Sparrow Herbert-Herman Cancer Center, Lansing, MI
⁷Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
⁹Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Sheila K Pierson, MSc^1*, Karan Kanhai, MD, PhD^2*, Adam Bagg, MD³, Daisy Alapat, MD⁴, Megan S. Lim, MD, PhD⁵, Mary Jo Lechowicz, MD⁶, Gordan Srkalovic, MD, PhD⁷, Thomas S. Uldrick, MD, MS⁸, Frits van Rhee, MD PhD⁹ and David C Fajgenbaum, MD, MBA, MSc¹⁰

¹Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
²EUSA Pharma, Hemel Hempstead, United Kingdom
³Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
⁴Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
⁵Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁶Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
⁷Sparrow Herbert-Herman Cancer Center, Lansing, MI
⁸Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
¹⁰Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Theodora Alese^1*, Benjamin G Barwick, PhD², Vikas A. Gupta, MD, PhD³, Nisha Joseph, MD¹, Craig C. Hofmeister, MD, MPH⁴, Mala Shanmugam, PhD⁵, Jonathan L. Kaufman, MD⁶, Madhav V Dhodapkar, MD⁷, Sagar Lonial, MD, FACP⁸, Ajay K. Nooka¹ and Lawrence H. Boise, PhD⁷

¹Winship Cancer Institute, Emory University, Atlanta, GA
²Winship Cancer Institute / Hematology and Medical Oncology, Emory University, Atlanta, GA
³Winship Cancer Institute/ Hematology and Medical Oncology, Emory University, Atlanta, GA
⁴Winship Cancer Institute / Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁵Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA
⁶Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁷Emory University, Atlanta, GA
⁸Emory University School of Medicine, Atlanta, GA

Anwar Khan^1*, Nagehan Pakasticali, MD², Omar Fathalla^2*, Taiga Nishihori, MD³ and Mohammad O Hussaini, MD^4*

¹Florida State University, Tallahassee, FL
²University of South Florida, Tampa, FL
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴Department of Hematopathology and Lab Medicine, Moffitt Cancer Center, Tampa, FL

Meera Mohan, MD¹, Sneha Nagavally, MS^2*, Binod Dhakal, MBBS¹, Saurabh Chhabra, MD, MS³, Anita D'Souza, MD^4* and Parameswaran Hari⁵

¹Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Medical college of Wisconsin, Milwaukee, WI
³Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Malignant Hematology and BMT, Froedtert and Medical College of Wisconsin Cancer Center, Wauwatosa, WI
⁵Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Meera Mohan, MD¹, Zimu Gong, MD^2*, Samantha Kendrick, PhD^3*, Sharmilan Thanendrarajan, MD⁴, Carolina Schinke, MD⁴, Daisy Alapat^5*, Guido Tricot, MD, PhD⁴, Fenghuang Zhan, MD. PhD⁶, Frits van Rhee, MD PhD⁴, Jeffery R. Sawyer^7*, Erming Tian, PhD, MBA⁸ and Maurizio Zangari, MD, FACP⁴

¹Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Baylor Scott & White Charles A. Sammons Cancer Center, Houston, TX
³Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
⁵UAMS, Little Rock, AR
⁶Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer InstituteMyeloma Center, Division of Hematology and Oncology/Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁷Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁸Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR

Wei Yee Chan, MBBS, MRCP^1*, Lara Howells, MBChB, MRCP^2*, William Wilson^3*, Emilie Sanchez, MD^4*, Louise Ainley, BMBCh, MA(Oxon), MRCP^2*, Selina J Chavda, MBBS, BSc, MRCP, FRCPATH^2*, Emma Dowling^5*, Nuno Correia^5*, Catherine SY Lecat, MBBS^2*, Annabel McMillan, MD^2*, Brendan Wisniowski, MD^2*, Shameem Mahmood, MD^2*, Xenofon Papanikolaou, MD^2*, Lydia Lee, MD, PhD^2*, Jonathan Sive, MD^2*, Charalampia Kyriakou, MD, PhD⁶, Ashutosh D. Wechalekar^7*, Rakesh Popat, MBBS, FRCPath, PhD^8*, Neil K Rabin, MD, PhD^2*, Eleni Nastouli, MD^4*, Kwee Yong, MD, PhD^9* and Ke Xu, MD, MRCP, FRCPath²

¹Department of Haematology, University College London Hospitals NHS Foundation Trust, Wembley, United Kingdom
²Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom
⁴Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Department of Haematology, HCA Healthcare UK at University College London Hospitals, London, United Kingdom
⁶University College London Hospital, UCLH Centre for Waldenström and Related Conditions, London, United Kingdom
⁷University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁸University College London Hospitals, NHS Foundation Trust, London, United Kingdom
⁹Department of Haematology, Univer, London, United Kingdom

Fnu Amisha, MD¹, Manojna Konda, MD^2*, Paras Malik, MD^3*, Tyler Fugere, MD^1*, Arya Mariam Roy, MD^4* and Akash Mukherjee, MD⁵

¹Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
²Department of Haematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
³Department of Internal Medicine, Albert Einstein College of Medicine- Jacobi Medical center, Bronx, NY
⁴Department of Haematology and Oncology, Roswell park comprehensive cancer center, Amherst, NY
⁵Department of Haematology/Oncology, Division of Stem cell transplantation and Cellular Therapy, University of Arkansas for Medical Sciences, Little Rock, AR

Sagar Rakshit, MD, Radhika Bansal, MBBS^*, Prashant Kapoor, MD, Angela Dispenzieri, MD^*, Morie A. Gertz, M.D., Martha Q. Lacy, MD, Suzanne R. Hayman, M.D., Francis K. Buadi, MB, CHB^*, Yi L. Hwa, NP, Amie Fonder, PA-C, MS^*, Miriam A. Hobbs, APRN, CNP, DNP^*, Wilson I Gonsalves, MD, Eli Muchtar, MD^*, David Dingli, M.D., Ph.D., Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD^*, Shaji K Kumar, MD and Nelson Leung, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Karthik Ramasamy¹, Herve Avet-Loiseau², Cecilie Hveding Blimark^3*, Michel Delforge⁴, Francesca Gay^5*, Salomon Manier, MD, PhD⁶, Joaquin Martinez-Lopez^7*, Maria-Victoria Mateos⁸, Mohamad Mohty, MD, PhD⁹, Niels W.C.J. van de Donk¹⁰ and Katja Weisel^11*

¹Oxford University Hospitals NHS Foundation Trust, Radcliffe Department of Medicine, Oxford University, Oxford, United Kingdom
²University Institute of Cancer Toulouse and University Hospital of Toulouse, Toulouse, France
³Sahlgrenska University Hospital, Gothenburg, Sweden
⁴University Hospital Leuven, Leuven, Belgium
⁵University of Turin, Turin, Italy
⁶University of Lille, Lille, France
⁷Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
⁸University Hospital of Salamanca / Salamanca Biomedical Research Institute, Salamanca, Spain
⁹Hospital Saint-Antoine and Sorbonne University, Paris, France
¹⁰Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
¹¹University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Saurabh Zanwar, MD, MBBS¹, Matthew Ho, MBBCh, BAO, PhD^2*, Prashant Kapoor, MD³, Angela Dispenzieri, MD⁴, Morie A. Gertz, M.D.³, Martha Q. Lacy, MD⁵, Francis K. Buadi, MB, CHB^6*, Suzanne R. Hayman, M.D.³, David Dingli, M.D., Ph.D.³, Taxiarchis Kourelis, MD³, Amie Fonder, PA-C, MS^3*, Yi L. Hwa, NP³, Miriam A. Hobbs, APRN, CNP, DNP^3*, Wilson I Gonsalves, MD⁷, Rahma M Warsame, MD³, Eli Muchtar, MD⁸, Nelson Leung, MD⁵, Robert A. Kyle, MD³, S. Vincent Rajkumar, MD^9* and Shaji K Kumar, MD³

¹Division of Hematology, Mayo Clinic, Rochester
²Department of Internal Medicine, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁶Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁷Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁸Division of Hematology, Mayo Clinic Rochester, Saint Paul, MN
⁹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Nizar J. Bahlis, MD¹, Jonathan L. Kaufman, MD², Rachid Baz, MD^3*, Hang Quach, FRACP, FRCPA⁴, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res^5*, Annette J. Vangsted, MD^6*, Torben Plesner, MD⁷, Philippe Moreau, MD, PhD^8*, Simon D. Gibbs^9*, Eva Medvedova, MD^10*, Orlando F. Bueno, MD, PhD¹¹, Yan Luo, MD PhD^11*, Christine Mantis, PhD^11*, Deeksha Vishwamitra, PhD^11*, Jeremy A. Ross, PhD^12* and Simon J Harrison, MD¹³

¹Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
³Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴St. Vincent’s Hospital, Melbourne, VIC, Australia
⁵Department of Haematology, St George Hospital, Sydney, Australia
⁶Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁷Department of Hematology, Vejle Hospital, Vejle, Denmark
⁸University Hospital Hôtel-Dieu, Nantes, Nantes, France
⁹The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Easter Health Clinical School, Melbourne, VIC, Australia
¹⁰Oregon Health & Science University, Portland, OR
¹¹AbbVie, Inc., North Chicago, IL
¹²AbbVie Inc., North Chicago, IL
¹³Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Nizar J. Bahlis, MD¹, Shambavi Richard^2*, Darrell J. White, MD³, Sebastian Grosicki, MD, PhD⁴, Christine Chen, MHPE, MD, FRCPC^5*, Sosana Delimpasi, MD^6*, Heather J. Sutherland, MD, PhD, FRCPC⁷, Zvenyslava Maslyak, MD^8*, Michael Sebag, MD, PhD⁹, Maria Gavriatopoulou, MD^10*, Suzanne Lentzsch, MD, PhD^11*, Ajai Chari, MD^12*, Maryana Simonova, MD^13*, Ivan Spicka, MD, Prof, PhD^14*, Iryna Kriachok^15*, Meletios A. Dimopoulos, MD¹⁶, Halyna Pylypenko, MD^17*, Holger W Auner, MD, PhD¹⁸, Xavier Leleu, MD¹⁹, Ganna Usenko, MD^20*, Roman Hajek, MD, PhD²¹, Reuben Benjamin, MD²², Tuphan Kanti Dolai, MBBS, MD, DNB, DM^23*, Dinesh Kumar Sinha, MD^24*, Christopher P. Venner, MD, FRCPC²⁵, Mamta Garg, MD, FRCP, FRCPath^26*, Don Stevens, MD²⁷, Hang Quach, FRACP, FRCPA²⁸, Sundar Jagannath, MD^29*, Philippe Moreau, MD, PhD^30*, Moshe Levy, MD^31*, Ashraf Z. Badros, MD³², Larry D. Anderson Jr., MD, PhD^33*, Thierry Facon, MD^34*, Maria-Victoria Mateos³⁵, Michele Cavo, MD, PhD^36*, Andrew DeCastro, PhD^37*, Yi Chai, PhD^38*, Dane R. Van Domelen, PhD^37*, Moran Mishal, MD^38*, Ohad S. Bentur, MD MHA^37*, Jatin Shah, MD³⁸, Sharon Shacham, PhD, MBA^37*, Michael G. Kauffman, MD, PhD³⁷ and Paul G. Richardson, MD³⁹

¹Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
²Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
⁴Silesian Medical University, Katowice, Poland
⁵Princess Margaret Cancer Center, Toronto, Canada
⁶Hematology/Lymphomas and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁷Division of Hematology, Vancouver General Hospital, Vancouver, BC, Canada
⁸State Institution "Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine", Lviv, Ukraine
⁹Royal Victoria Hospital, Montreal, QC, Canada
¹⁰Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens,, Athens, Greece
¹¹Medical Oncology, Columbia University Medical Center, New York, NY
¹²Mount Sinai, New York, NY
¹³Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
¹⁴Charles University and General Hospital, Prague, Czech Republic
¹⁵National Cancer Institute, Kiev, Ukraine
¹⁶Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
¹⁷Department of Hematology, Cherkassy Regional Oncology Center, Cherkassy, Ukraine
¹⁸Imperial College London, London, United Kingdom
¹⁹Department of Hematology, CHU Poitiers – Hôpital la Milétrie, Poitiers, France
²⁰City Hematology Center, City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine
²¹Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
²²Department of Haematology, Kings College Hospital NHS Foundation Trust, London, CA, United Kingdom
²³Haematology, Nil Ratan Sircar Medical College and Hospital, Kolkata, India
²⁴State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India
²⁵Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
²⁶Leicester Royal Infirmary, Leicester, United Kingdom
²⁷Norton Healthcare, Norton Cancer Institute, Louisville, KY
²⁸University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
²⁹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³⁰University Hospital Hotel-Dieu, Nantes, France
³¹Baylor University Medical Center, Dallas, TX
³²School of Medicine, University of Maryland Baltimore, Baltimore, MD
³³UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
³⁴CHU Lille Service des Maladies du Sang F-59000, Lille, France
³⁵Hospital Clinico Universitario de Salamanca, Salamanca, Spain
³⁶IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
³⁷Karyopharm Therapeutics Inc., Newton, MA
³⁸Karyopharm Therapeutics, Newton, MA
³⁹Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA

Yuxin Liu, MD¹, Bohm Kywe, MD^2*, Lake Crawford^3*, Federico Lora^4*, Noffar Bar, MD¹, Sabrina L. Browning, MD¹, Elan Gorshein, DO, JD, MPH^5*, Terri L. Parker, MD¹ and Natalia Neparidze, MD³

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
²Department of Internal Medicine, Norwalk Hospital, Norwalk, CT
³Yale University School of Medicine, New Haven, CT
⁴Cancer Research Opportunities for Youth (CROY) Program, Yale Cancer Center, New Haven, CT
⁵Smilow Cancer Hospital Care Center- Guilford, Yale University School of Medicine and Yale Cancer Center, Guilford, CT

Efstathios Kastritis^1*, Maria Gavriatopoulou, MD^1*, Maria Roussou, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD, MSc, PhD^1*, Magdalini Migkou, MD, PhD^1*, Nikolaos Kanellias, MD^1*, Despina Fotiou, MD, PhD^1*, Foteini Theodorakakou, MD^1*, Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD^1*, Panagiotis Malandrakis, MD^1*, Vasiliki Spiliopoulou, MD^1*, Stavroula Giannouli, MD, PhD^2*, Evangelos Terpos, MD, PhD¹ and Meletios A. Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Second Department of Internal Medicine, Hematology Unit, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Hsin-An Hou, MD, PhD^1*, Chao-Hsiun Tang, BA, PhD^2*, Choo Hua Goh^3*, Sarah Siggins, PhD^4*, Shih-Pei Shen^2*, Hong Qiu, MD, PhD^5*, Wen-Chien Chou, MD, PhD⁶ and Yanfang Liu, MD, MPH^3*

¹Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
²School of Health Care Administration, Taipei Medical University, Taipei, Taiwan
³Global Epidemiology, Janssen Research & Development, Singapore, Singapore
⁴Janssen Medical Affairs, Macquarie Park, Australia
⁵Janssen Research & Development, Titusville
⁶Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Louise Redder, MD^1*, Sören Möller^2*, Anna Thit Johnsen^3*, Mary Jarden^4*, Christen lykkegaard Andersen^5*, Henrik Frederiksen, M.D., Ph.D.^1,6,7*, Henrik Gregersen, MD, PhD^8*, Anja Klostergaard^9*, Morten Saaby Steffensen^10*, Per Troellund Pedersen^11*, Maja Hinge^12*, Mikael Frederiksen^13*, Carsten Helleberg, MD^14*, Niels Abildgaard, M.D.^15,16,17 and Lene Kongsgaard Nielsen^18,19*

¹Department of Hematology, Odense University Hospital, Odense, Denmark
²OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark and Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, DNK
³Department of Psychology, University of Southern Denmark, Odense, Denmark
⁴The University Hospitals Centre For Health Research, Rigshospitalet, Copenhagen, DNK
⁵Department of Haematology, Zealand University Hospital, Roskilde, DNK
⁶Department of Clinical Research, University of Southern Denmark, Odense, Denmark
⁷Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
⁸Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
⁹7Department of Haematology, Aarhus University Hospital, Denmark, AArhus, Denmark
¹⁰Department of Haematology, Regional Hospital West Jutland, Denmark, Holstebro, DNK
¹¹Department of Haematology, South West Jutland Hospital, Denmark, Esbjerg, Denmark
¹²Department of Haematology, Vejle Hospital, Denmark, Vejle, DNK
¹³Department of Hematology, Sygehus Soenderjylland, Aabenraa, Denmark
¹⁴Department of Hematology, Herlev Hospital, Herlev, Denmark
¹⁵Center for Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
¹⁶Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
¹⁷Clinical Institute, University of Southern Denmark, Odense, Denmark
¹⁸Quality of Life Research Center, Department of Haematology, Odense University Hospital, Denmark, Odense, DNK
¹⁹13 Research Unit for Multimorbidity, Department of Internal Medicine and Cardiology, Viborg Regional Hospital, Denmark, Viborg, Denmark

Iuliana Vaxman, MD, BA^1,2,3*, Jithma P. Abeykoon, MD⁴, Angela Dispenzieri, MD⁵, Shaji K Kumar, MD⁵, Francis K. Buadi, MB, CHB^2*, Martha Q. Lacy, MD⁶, David Dingli, M.D., Ph.D.⁴, Yi Lisa Hwa, CNP, DNP^4*, Amie Fonder, PA-C, MS^4*, Miriam A. Hobbs, APRN, CNP, DNP^4*, Craig B. Reeder, MD⁷, Taimur Sher, MD⁸, Suzanne R. Hayman, M.D.⁴, Taxiarchis Kourelis, MD⁴, Rahma M Warsame, MD⁴, Eli Muchtar, MD⁹, Nelson Leung, MD⁶, Wilson I Gonsalves, MD¹⁰, Mustaqeem A. Siddiqui, M.D., M.B.A.⁴, Robert A. Kyle, MD⁴, S. Vincent Rajkumar, MD^11*, Kirsten McCullough^5*, Prashant Kapoor, MD⁴ and Morie A. Gertz, M.D.⁴

¹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN
⁶Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁸Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁹Division of Hematology, Mayo Clinic Rochester, Saint Paul, MN
¹⁰Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
¹¹Division of Hematology, Mayo Clinic, Rochester

Motiur Rahman^1*, Christopher Kim, PhD, MPH², Jazmine Mateus, MPH^3* and Alissa Keegan, MD, PhD²

¹Amgen, Thousand Oaks, CA
²Amgen Inc, Thousand Oaks, CA
³DOCS, Philadelphia, PA

Angelo Belotti, MD^1*, Rossella Ribolla, MD^1*, Alberta Villanacci^2*, Marco Chiarini, MSc^3*, Viviana Giustini, MSc^3*, Giulia Vittoria Facchetti^4*, Claudia Crippa, MD^1*, Valeria Cancelli, MD^1*, Samantha Ferrari^1*, Annalisa Peli, MD^1*, Chiara Bottelli, MD^1*, Chiara Cattaneo, MD^5*, Chiara Saeli^6*, Aldo M. Roccaro, MD, PhD⁷, Luigi Grazioli, MD^8*, Giuseppe Rossi, MD⁹ and Alessandra Tucci, MD^10*

¹Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
²Radiology, ASST Spedali Civili di Brescia, Brescia, Italy
³Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
⁴Hematology, ASST Spedali Civili di Brescia, 25123, Italy
⁵Hematology, ASST Spedali Civili di Brescia, Brescia, BS, Italy
⁶Department of Radiology, Spedali Civili di Brescia, Brescia, Italy
⁷Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy
⁸Department of Radiology, ASST- Spedali Civili di Brescia, brescia, Italy
⁹Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁰Hematology, ASST Spedali Civili, Brescia, Italy

Tahani Atieh, DO¹, Shebli Atrash, MD², Meera Mohan, MD, MS^3*, Leyla Shune, MD¹, Zahra Mahmoudjafari, PhD^4*, Julie Quick^5*, Justin Riffel^5*, Joseph P. McGuirk, DO⁴, Ghulam Rehman Mohyuddin, MD⁶, Al-Ola Abdallah, MD⁷, Nausheen Ahmed, MD^4*, Wei Cui^5* and Anne Wishna^5*

¹University of Kansas Cancer Center, Westwood, KS
²Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, University of Arkansas for Medical Sciences, Charlotte, NC
³Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁵University of Kansas Medical Center, Kansas City, KS
⁶University of Utah, Salt Lake City, UT
⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Alina Varabyeva, PharmD^1*, Jens Hillengass², Wenyan Ji, MA^3*, Han Yu, PhD^4*, McKenna Butler, PharmD^5* and Eugene Przespolewski, PharmD^6*

¹Roswell Park Comprehensive Cancer Center, BUFFALO, NY
²Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY
⁵NYU Langone Hospital- Long Island, Mineola, NY
⁶Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Malin Hultcrantz, MD PhD¹, Jennifer Orozco, PharmD^2*, Tim J Peterson, PharmD^2*, Andriy Derkach, PhD^3*, Hani Hassoun, MD¹, Neha Korde, MD¹, Sydney X. Lu, MD, PhD¹, Sham Mailankody, MBBS ¹, Dhwani Patel, MD^1*, Urvi A Shah, MD^1*, Carlyn Tan, MD^1,4, Kylee H Maclachlan, MD, PhD, BSc, FRACP, FRCPA¹, David J. Chung, MD, PhD⁵, Heather J Landau, MD⁶, Gunjan L Shah, MD^7*, Oscar B Lahoud, MD⁷, Michael Scordo, MD⁸, Ola Landgren, MD⁹, Sergio Giralt, MD^10* and Alexander Lesokhin, MD⁴

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Pharmacy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁹Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
¹⁰Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY